Khan, Imran
Spencer-Smith, Russell
O’Bryan, John P.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (CA192822)
Article History
Received: 19 July 2018
Revised: 1 November 2018
Accepted: 28 November 2018
First Online: 20 December 2018
Change Date: 1 February 2019
Change Type: Correction
Change Details: Additionally, a further error has been corrected on page five in the sentence: Subsequent improvements to the chemistry of these lead compounds have resulted in the most recent interaction, with ARS-1620, which demonstrates selective inhibition of K-RAS(G12C) mutant tumor models in vivo [23]. The word ‘with’ has been removed from this sentence to ensure the correct meaning is communicated, such that the sentence now is: Subsequent improvements to the chemistry of these lead compounds have resulted in the most recent interaction, ARS-1620, which demonstrates selective inhibition of K-RAS(G12C) mutant tumor models in vivo [23].
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.